Search Orphan Drug Designations and Approvals
-
| Generic Name: | fixed dose combination of methimazole and liothyronine |
|---|---|
| Date Designated: | 03/06/2017 |
| Orphan Designation: | Treatment of brain metastases in patients with primary lung cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Musli Thyropeutics Ltd. 6 Hagefen Street P. O. Box 529 Zur Moshe Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
-
